Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 5,000 shares at $22.28 ($111K) on 2014-05-19, disclosed to the SEC on 2014-05-21.
Scheduled sale ($111k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.28 | 2,450 | $55K | 49.0% |
| 2 | $22.28 | 2,550 | $57K | 51.0% |
| Total | $22.28 avg | 5,000 | $111K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |